Vectibix 100 mg Infusion 5 ml belongs to a class of monoclonal antibodies. It is used alone or with other anticancer medicines to treat wild-type RAS metastatic colorectal cancer (mCRC). Metastatic colorectal cancer (mCRC) is a type of cancer of the colon or rectum that has spread to other areas of the body.

Vectibix 100 mg Infusion 5 ml contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.

Vectibix 100 mg Infusion 5 ml will be administered under the supervision of a physician qualified by training and an experienced oncologist. The most frequent side effects of Vectibix 100 mg Infusion 5 ml when taken with other chemotherapy medications include diarrhea, paronychia (nail inflammation), fatigue, nausea, and diarrhea; stomatitis (oral mucosal inflammation and redness), mucosal inflammation, asthenia (abnormal physical weakness), anorexia, hypomagnesemia (an electrolyte disturbance), hypokalemia, rash, skin rash, itchiness, and dry skin. You should talk to your doctor if these side effects persist or worsen.

Notify your doctor of any food or medication allergies or hypersensitivity reactions before taking the Vectibix 100 mg Infusion 5 ml. Vectibix 100 mg Infusion 5 ml may cause fetal harm when administered to a pregnant woman. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner become pregnant while undergoing therapy. Breastfeeding is not recommended while taking panitumumab. 

Vectibix 100 mg Infusion 5 ml contains Panitumumab, a monoclonal antibody. It is used alone or in conjunction with other anticancer medications to treat metastatic colorectal cancer (mCRC). It works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.

• Paronychia (nail inflammation)
• Fatigue
• Nausea
• Diarrhea
• Stomatitis (inflammation and redness of the oral mucosa)
• Mucosal inflammation
• Asthenia (abnormal physical weakness)
• Anorexia
• Hypomagnesemia
• Hypokalemia
• Rash
• Skin rash
• Pruritus
• Feeling sick
• Dry skin

Before taking Vectibix 100 mg Infusion 5 ml, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. The dosage of this medicine will be based on your health condition. Your doctor may adjust your dose during therapy based on the treatment results. Vectibix 100 mg Infusion 5 ml may cause infusion reactions, interstitial lung disease (ILD), ocular toxicity, and dermatologic or soft tissue toxicity. Hence, inform the doctor immediately if you suffer any side effects. If therapy needs to be stopped, your doctor will make that decision. Vectibix 100 mg Infusion 5 ml is recommended not to be used in pregnant women. Therefore, if you become pregnant while on treatment with Panitumumab, tell your doctor immediately. Breastfeeding is not recommended while taking panitumumab. Alcohol should be avoided during treatment with this medicine. Drive only if alert, as the Vectibix 100 mg Infusion 5 ml may cause nausea or tiredness.

Drug-Drug Interactions: Vectibix 100 mg Infusion 5 ml may interact with certain medications used to treat actinic keratoses (e.g. aminolevulinic acid), antiarrhythmic drugs (e.g. amiodarone, dronedarone), anti-cancer medications (e.g. bevacizumab) and antipsychotic drug (e.g. ziprasidone).

Drug-Food Interactions: Avoid the consumption of alcoholic beverages.

Drug-Disease Interactions: Vectibix 100 mg Infusion 5 ml may interact with disease conditions, including dermatologic toxicities, ocular infection (eye infection), pulmonary impairment, liver disease, renal dysfunction, cardiovascular disease, electrolyte abnormalities, hypokalemia (low potassium levels), hypocalcemia (low calcium levels), heart disease, magnesium imbalance.

• AMINOLEVULINIC ACID
• AMIODARONE
• DRONEDARONE
• BEVACIZUMAB
• ZIPRASIDONE

• After your treatment begins, several dietary adjustments can help you control side effects.
• Anyone suffering from a chronic illness, including cancer, should consume foods high in protein, healthy fats, whole grains, and vitamins and minerals.
• Plant-based proteins are among the best meals to take during chemotherapy or other cancer treatments. They have the highest concentrations of vitamins and minerals, such as nuts, seeds, beans, and legumes.
• Eat a healthy diet and exercise regularly to maintain a proper weight.
• Include leafy vegetables, citrus fruits, fatty fish, berries, yogurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
• De-stress yourself by meditating, reading books, taking a warm bubble bath, or listening to soothing music.
• Performing yoga may also help improve both physical and mental health.
• Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
• Get optimal sleep; rest well.
• Avoid smoking and alcohol consumption.
• Avoid fast and fried foods, processed meats, refined carbs, and added sugars.

• Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to Vectibix 100 mg Infusion 5 ml.
• Pregnancy testing is recommended prior to starting treatment with Vectibix 100 mg Infusion 5 ml.
• Do not donate sperm throughout treatment and at least two months after treatment.

Cancer: Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Types of cancer include blood, lung, breast, etc. Cancer growth can be prevented by chemotherapy, radiation, and stem cell therapy.

Metastatic colorectal cancer (mCRC): Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Metastasis means that the cancer cells have spread beyond the colon to other organs. This is also referred to as advanced colon cancer or stage IV colon cancer.